Silvergleid A J
JAMA. 1987 Jun 26;257(24):3403-4.
Although there is documentation in the literature of the safety and effectiveness of predeposit autologous transfusions among adult patients contemplating surgery, there are no comparable data for preteen and teenage children. We report our experience with 180 children between the ages of 8 and 18 years participating in a community blood center-based predeposit autologous transfusion program. Children as young as 8 years old and weighing as little as 27 kg predonated a prescribed amount of blood prior to elective orthopedic (169) or plastic (11) surgery. Only four children experienced a donor reaction; none of them was severe. No child was unable to donate the prescribed number of units. Eighty-eight percent of the children were able to supply their complete blood requirements, thus avoiding exposure to homologous blood. Our experience documents both the safety and effectiveness of predeposit autologous transfusions in preteen and adolescent children and should encourage existing predeposit autologous transfusion programs to extend participation to thousands of children for whom the opportunity to use their own blood is currently denied.
虽然文献中有关于成年手术患者预存自体输血安全性和有效性的记录，但对于十几岁前的儿童却没有类似数据。我们报告了180名年龄在8至18岁之间的儿童参与社区血库预存自体输血项目的经验。年仅8岁、体重低至27公斤的儿童在择期骨科手术（169例）或整形手术（11例）前预先捐献了规定量的血液。只有4名儿童出现供血反应，且均不严重。没有儿童无法捐献规定数量的单位血液。88%的儿童能够提供自身所需的全部血液，从而避免接触异体血。我们的经验证明了预存自体输血在十几岁前儿童和青少年中的安全性和有效性，应促使现有的预存自体输血项目将参与范围扩大到成千上万目前没有机会使用自身血液的儿童。
